Tech Company Financing Transactions
Alleviant Medical Funding Round
Alleviant Medical, operating out of Austin, scored $90 million in investment from Gilde Healthcare Partners, Gilmartin Capital and Longview International.
Transaction Overview
Company Name
Announced On
1/15/2025
Transaction Type
Venture Equity
Amount
$90,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to conduct its second pivotal trial. The new pivotal trial, ALLAY-HFrEF, will be the first prospective sham-controlled trial focused on patients with heart failure and reduced ejection fraction (HFrEF) in the atrial shunt space.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7801 N Lamar Blvd D-106
Austin, TX 78752
USA
Austin, TX 78752
USA
Phone
Undisclosed
Website
Email Address
Overview
Alleviant Medical is a medical device company developing a minimally invasive, implant-free interatrial shunt device under clinical investigation for the treatment of chronic heart failure. Enrollment in Alleviant's randomized sham-controlled global study to evaluate its no-implant device is forthcoming.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adam Berman
Browse more venture capital transactions:
Prev: 1/14/2025: First Ascent Biomedical venture capital transaction
Next: 1/15/2025: Visby Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs